News and Events
Learn more about current happenings at Ergomed.
In the race to develop suitable treatments for COVID-19, drug repurposing methodologies – which are commonly used in rare disease drug development – offer the opportunity to generate more treatment options rapidly and with lower cost.
In this webinar, Ergomed’s experts shared their insights into how they are supporting collaboration between industry, academia and clinicians on the frontline of the fight against COVID-19. From garnering the support of KOLs and investigators, development of scientifically sound and clinically operable protocols and navigating the regulatory pathways… to overcoming the associated hurdles in drug development.
Topics covered in this webinar included:
Presenters:
Click here to watch the webinar